The Illumina-backed DNA and RNA sequencer provider raised the funding from investors including GIC, Hostplus and China Construction Bank.
Oxford Nanopore Technologies, a UK-based gene sequencing technology developer that counts genomics technology producer Illumina as an investor, raised £100m ($140m) in funding today.
The round included GIC, the sovereign wealth fund of Singapore, as well as Australian superannuation fund Hostplus and financial services firm China Construction Bank along with unnamed existing shareholders.
Founded in 2005, Oxford Nanopore has developed real-time DNA and RNA sequencing technology that offers low-cost biological analysis through products such as the portable Minion, the desktop…
